Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]. (2021)
Attributed to:
STEROID PROTECTION FROM TUBERCULOSIS-ASSOCIATED IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.16783.1
PubMed Identifier: 34286103
Publication URI: http://europepmc.org/abstract/MED/34286103
Type: Journal Article/Review
Volume: 6
Parent Publication: Wellcome open research
ISSN: 2398-502X